REvision of VSG with Ablation of the Mucosa Procedure
NCT06671119
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to evaluate the feasibility, safety, and tolerability of endoscopic selective gastric mucosal ablation (GMA) using argon plasma coagulation after sleeve gastrectomy. In this study, GMA will be performed on patients who have experienced weight regain following an initial successful response to sleeve gastrectomy.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Obesity and Obesity-related Medical Conditions
- Obesity and Overweight
- Obesity Prevention
- Obesity Recidivism
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 22 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Dr. Christopher McGowan
- Last updated on ClinicalTrials.gov
- November 5, 2024
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
North Carolina · 1
- True You Weight Loss · Cary, NC
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.